By Richard Pazdur MD – I am honored to be selected by Commissioner Califf as the acting director of FDA’s new Oncology Center of Excellence (OCE) in support of the Vice President’s National Cancer Moonshot Initiative.
By Kathleen “Cook” Uhl MD – At FDA’s Office of Generic Drugs (OGD) in the Center for Drug Evaluation and Research, 2015 was an important year. It was our first full year of operation after vastly expanding our office’s scope and structure
By Taha A. Kass-Hout MD, MS & Elaine Johanson – Imagine a world where doctors have at their fingertips the information that allows them to individualize a diagnosis, treatment or even a cure for a person based on their genes. That’s what President Obama envisioned when he announced his Precision Medicine Initiative earlier this year.
By Stephen M. Ostroff MD – Last week our nation lost a true pioneer in public health and consumer protection. Frances Oldham Kelsey, Ph.D., M.D., who joined FDA in 1960 as a medical officer, was known worldwide as a leader in drug safety and the protection of patients.
By Jonca Bull – April is Minority Health Month! I am proud to say that FDA’s Office of Minority Health (OMH), in collaboration with the Department of Health and Human Service’s Office of Minority Health, is celebrating this year’s theme: “30 Years of Advancing Health Equity, The Heckler Report: A Force for Ending Health Disparities in America.”
©2024 Answers Media Company, LLC